Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wave Life Sciences (WVE) Other Non-Current Assets: 2015-2024

Historic Other Non-Current Assets for Wave Life Sciences (WVE) over the last 10 years, with Dec 2024 value amounting to $3.8 million.

  • Wave Life Sciences' Other Non-Current Assets rose 1.33% to $3.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.8 million, marking a year-over-year increase of 1.33%. This contributed to the annual value of $3.8 million for FY2024, which is 1.62% up from last year.
  • Wave Life Sciences' Other Non-Current Assets amounted to $3.8 million in FY2024, which was up 1.62% from $3.7 million recorded in FY2023.
  • Over the past 5 years, Wave Life Sciences' Other Non-Current Assets peaked at $3.8 million during FY2024, and registered a low of $3.7 million during FY2020.
  • For the 3-year period, Wave Life Sciences' Other Non-Current Assets averaged around $3.7 million, with its median value being $3.7 million (2023).
  • Per our database at Business Quant, Wave Life Sciences' Other Non-Current Assets tumbled by 65.28% in 2020 and then climbed by 1.62% in 2024.
  • Yearly analysis of 5 years shows Wave Life Sciences' Other Non-Current Assets stood at $3.7 million in 2020, then remained steady at $3.7 million in 2021, then remained steady at $3.7 million in 2022, then remained steady at $3.7 million in 2023, then grew by 1.62% to $3.8 million in 2024.